Cargando…

Task Specific Tremor in Parkinson’s Disease Responds to Apomorphine

BACKGROUND: Task specific tremor (TST) is a poorly understood entity without any standard treatments, that may subsequently develop tremor during additional tasks, later develop postural/kinetic tremor (essential tremor criteria), and later develop Parkinson’s disease. The pathophysiology is not und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ondo, William G., Koneru, Vindhya, Arif, Chia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237238/ https://www.ncbi.nlm.nih.gov/pubmed/37275945 http://dx.doi.org/10.5334/tohm.764

Ejemplares similares

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016)

Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?
por: Hauser, Robert A., et al.
Publicado: (2023)

Apomorphine in Parkinson's Disease—The Questions Raised
por: Dhamija, Rajinder K., et al.
Publicado: (2020)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
por: Agbo, Felix, et al.
Publicado: (2021)

Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
por: Wang, Xi-Xi, et al.
Publicado: (2020)

Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
por: Desjardins, Clément, et al.
Publicado: (2023)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Apomorphine
Publicado: (1900)

Apomorphine
Publicado: (1888)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
por: Borkar, Nrupa, et al.
Publicado: (2018)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

Task-Specific Drinking Tremor
por: Benedek, Krisztina, et al.
Publicado: (2023)

Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
por: Pieroni, Miguel A.
Publicado: (2019)

Tremor Research Group Essential Tremor Rating Scale (TETRAS): Assessing Impact of Different Item Instructions and Procedures
por: Ondo, William G., et al.
Publicado: (2020)

Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: A Systematic Review
por: Gaire, Suman, et al.
Publicado: (2021)

Task-Oriented Intelligent Solution to Measure Parkinson's Disease Tremor Severity
por: AlMahadin, Ghayth, et al.
Publicado: (2021)

On the Anæsthetic Action of Apomorphine
Publicado: (1885)

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study
por: Kassubek, Jan, et al.
Publicado: (2023)

A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Apomorphine effects on the hippocampus
por: Arroyo-García, Luis Enrique, et al.
Publicado: (2018)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease
por: Nishijima, Haruo, et al.
Publicado: (2018)

Thalamic Deep Brain Stimulation for Orthostatic Tremor
por: Yaltho, Toby C., et al.
Publicado: (2011)

Using Deep Learning for Task and Tremor Type Classification in People with Parkinson’s Disease
por: Farhani, Ghazal, et al.
Publicado: (2022)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease
por: Thach, Andrew, et al.
Publicado: (2021)

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
por: Meira, Bruna, et al.
Publicado: (2021)

Retracted: Task-Oriented Intelligent Solution to Measure Parkinson's Disease Tremor Severity
por: Healthcare Engineering, Journal of
Publicado: (2023)

Essential Tremor: What We Can Learn from Current Pharmacotherapy
por: Ondo, William
Publicado: (2016)

Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
por: Henriksen, Tove, et al.
Publicado: (2023)

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
por: Zagnoli, Fabien, et al.
Publicado: (2023)

Some Observations on the Use of Apomorphine
por: Horsley, J. S.
Publicado: (1912)

Is Apomorphine a Safe Emetic?
por: Brown, John
Publicado: (1889)

On the Origin of Tremor in Parkinson’s Disease
por: Dovzhenok, Andrey, et al.
Publicado: (2012)

Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson’s Disease
por: Gupta, Deepak K., et al.
Publicado: (2020)

Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study
por: Agbo, Felix, et al.
Publicado: (2021)

Epidemiology and treatment of 23 musicians with task specific tremor
por: Lee, André, et al.
Publicado: (2014)

Parkinson’s tremor
por: Elias, Jeff, et al.
Publicado: (2015)

Re-Emergent Tremor of Parkinson’s Disease Masquerading as Essential Tremor
por: Morgan, Sarah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_if26bnqbfce08i20cvadb3q9bv